Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein

Add time:09/06/2019    Source:sciencedirect.com

Keratoconus (KC) is the most common ectatic corneal disease, with clinical findings that include discomfort, visual disturbance and possible blindness if left untreated. KC affects approximately 1:400 to 1:2000 people worldwide, including both males and females. The aetiology and onset of KC remains a puzzle and as a result, the ability to treat or reverse the disease is hampered. Sex hormones are known to play a role in the maintenance of the structure and integrity of the human cornea. Hormone levels have been reported to alter corneal thickness, curvature, and sensitivity during different times of menstrual cycle. Surprisingly, the role of sex hormones in corneal diseases and KC has been largely neglected. Prolactin-induced protein, known to be regulated by sex hormones, is a new KC biomarker that has been recently proposed. Studies herein discuss the role of sex hormones as a control mechanism for KC onset and progression and evidence supporting the view that prolactin-induced protein is an important hormonally regulated biomarker in KC is discussed.

We also recommend Trading Suppliers and Manufacturers of prolactin-like protein IV (cas 136253-31-1). Pls Click Website Link as below: cas 136253-31-1 suppliers

Prev:Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease
Next:Evaluation of prolactin-like activity produced by concanavalin-A stimulated mouse splenocytes☆)